http://money.cnn.com/quote/profile/profile.html?symb=GALT
paul pressler: https://relationshipscience.com/paul-h-pressler-p3170639
independent director
https://www.google.com/patents/US9649327
https://www.reuters.com/article/us-galectin-thera-nash/galectin-slumps-after-nash-drug-misses-main-goal-of-mid-stage-trial-idUSKBN1DZ1TL
(Reuters) - Galectin Therapeutics Inc said its drug for the complex progressive fatty liver disease NASH led to some clinically meaningful results in patients with cirrhosis, but failed to achieve the main goal of a mid-stage trial, sending its shares plunging 48 percent on Tuesday.
NASH, formally known as non-alcoholic Steatohepatitis, is seen as one of the fastest growing diseases in the developed world with no approved treatments. Many companies are trying to develop drugs to tackle various aspects of the condition, so far with minimal success.
The disease is poised to become the leading cause of liver transplants by 2020 with the eventual market forecast to be $20 billion to $35 billion as populations with fatty diets increasingly fall victim to the condition.
https://www.marketwatch.com/story/shareholder-alert-levi-korsinsky-llp-announces-an-investigation-concerning-possible-breaches-of-fiduciary-duty-by-certain-officers-and-directors-of-galectin-therapeutics-inc-2017-12-18
https://www.businesswire.com/news/home/20150317006012/en/Shuman-Law-Firm-Investigates-Galectin-Therapeutics
https://www.prnewswire.com/news-releases/ryan--maniskas-llp-announces-investigation-of-galectin-therapeutics-inc-269241251.html
class action: https://www.battea.com/galectin-therapeutics-receives-securities-class-action-lawsuit/
https://www.jdsupra.com/legalnews/dismissal-for-drugmaker-affirmed-51372/
https://us.gsk.com/en-us/media/press-releases/2014/serious-fraud-office-investigation/ Glaxo investigated for fraud the world over – Paxil marketing in 1992 and company his suicide risks. Bribing doctors to use botox injections. Bribign docs to use seretide in Poland,
https://wikileaks.org/gifiles/docs/14/1440535_tough-choices-big-opportunities-john-mauldin-s-weekly-e.html
“Dr. Traber, formerly in charge of global drug development for Glaxo, is a force in
himself and relatively new as the CEO. “
“Basically (to make a long story short), GALT has a deep repository of
research performed in the USSR prior to the fall of the Iron Curtain, on
carbohydrates. Russian and Eastern European scientists had traveled the
world looking for new carbohydrates in plants, etc., and the research
spanned many decades. When Russian science lost much of its funding, some
of those famous scientists came to the US and brought this research, which
was then quite new. In the West, we had concentrated on using proteins as
drugs, ignoring by and large their lowly sugary brethren.”
gaalectic therapy http://galectintherapy.com/
shareholders: http://investors.morningstar.com/ownership/shareholders-major.html?t=GALT
http://investor.galectintherapeutics.com/news-releases/news-release-details/galectin-therapeutics-inc-and-sbh-sciences-inc-announce?ReleaseID=821203
Form Galectin Sciences LLC for research in 2014
SBH takes government contract
http://government-contractors.insidegov.com/l/647833/Sbh-Sciences-Inc
mega donor Richard uihlein conservative causes: https://chicago.suntimes.com/news/mega-donor-richard-uihlein-ramps-up-donations-to-conservative-causes/
Board of directors:
https://www.bloomberg.com/research/stocks/private/board.asp?privcapId=1065415